. 2016 Mar 30;70(5):816–825. doi: 10.1177/0003702816638281
© The Author(s) 2016
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 2.
PCA-SVM plot for 19 pharmaceutical compounds based on the SVM model.